Current Innovations in Cancer Organoid Modeling for Drug Discovery

Join a comprehensive webinar exploring breakthrough developments in cancer organoid technology and its applications in drug screening. Learn from Dr. Colin Paul, Cell Biology R&D Staff Scientist at Thermo Fisher Scientific, and Dr. Thierry Jarde, Laboratory Head at Monash University, as they delve into establishing next-generation tumoroid models using novel culture systems and high content analysis platforms. Master the implementation of cancer organoids for high-throughput screening applications, optimize drug screening workflows for better consistency, and explore breast cancer disease modeling using patient-derived tumoroids. Understand why over 95% of potential anti-cancer drugs fail in clinical trials and discover innovative approaches to improve treatment efficacy and reduce drug candidate attrition rates. Gain valuable insights into functional precision medicine and learn how these advanced organoid models can be leveraged for large-scale studies and functional assay development to advance cancer research and patient care.